RETRACTED: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics

RETRACTED: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics

Alzheimer's disease (AD) is a neurodegenerative disease that affects a wide range of populations and is the primary cause of death in various countries. The treatment of AD is still restricted to oral conventional medicines that act only superficially. Fabrication of intranasal solid lipid nano...

Full description

Bibliographic Details
Main Authors: Deepshi Arora, Shailendra Bhatt, Manish Kumar, Ravinder Verma, Yugam Taneja, Nikita Kaushal, Abhishek Tiwari, Varsha Tiwari, Athanasios Alexiou, Sarah Albogami, Saqer S. Alotaibi, Vineet Mittal, Rajeev K. Singla, Deepak Kaushik, Gaber El-Saber Batiha
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Aging Neuroscience
Subjects:
Alzheimer
intranasal
rivastigmine
CCD
pharmacokinetics
ex vivo
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2022.960246/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2022.960246/full

Similar Items